These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes. Bancroft T; DeBuysscher BL; Weidle C; Schwartz A; Wall A; Gray MD; Feng J; Steach HR; Fitzpatrick KS; Gewe MM; Skog PD; Doyle-Cooper C; Ota T; Strong RK; Nemazee D; Pancera M; Stamatatos L; McGuire AT; Taylor JJ J Exp Med; 2019 Oct; 216(10):2331-2347. PubMed ID: 31345930 [TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients. Márquez-Coello M; Montes de Oca Arjona M; Martín-Aspas A; Guerrero Sánchez F; Fernández-Gutiérrez Del Álamo C; Girón-González JA Sci Rep; 2019 Aug; 9(1):11654. PubMed ID: 31406185 [TBL] [Abstract][Full Text] [Related]
5. The impact of active HIV-1 replication on the physiological age-related decline of immature-transitional B-cells in HIV-1 infected children. Cagigi A; Palma P; Nilsson A; Di Cesare S; Pensieroso S; Kakoulidou M; Bernardi S; Rossi P; Chiodi F AIDS; 2010 Aug; 24(13):2075-80. PubMed ID: 20588160 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals. Montezuma-Rusca JM; Moir S; Kardava L; Buckner CM; Louie A; Kim LJ; Santich BH; Wang W; Fankuchen OR; Diaz G; Daub JR; Rosenzweig SD; Chun TW; Li Y; Braylan RC; Calvo KR; Fauci AS J Immunol; 2015 Mar; 194(6):2561-8. PubMed ID: 25681347 [TBL] [Abstract][Full Text] [Related]
7. Anti-HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity. Dosenovic P; Kara EE; Pettersson AK; McGuire AT; Gray M; Hartweger H; Thientosapol ES; Stamatatos L; Nussenzweig MC Proc Natl Acad Sci U S A; 2018 May; 115(18):4743-4748. PubMed ID: 29666227 [TBL] [Abstract][Full Text] [Related]
8. [Silent HIV infection in HIV seronegative individuals?]. Waldum HL; Iversen OJ Tidsskr Nor Laegeforen; 1990 Mar; 110(8):997-8. PubMed ID: 2181734 [No Abstract] [Full Text] [Related]
9. HIV-1 and HIV-2 seropositivity among female sex workers in the Tenere Desert, Niger. Gragnic G; Julvez J; Abari A; Alexandre Y Trans R Soc Trop Med Hyg; 1998; 92(1):29. PubMed ID: 9692142 [No Abstract] [Full Text] [Related]
10. Acanthosis nigricans in an HIV seropositive: is there a correlation? Marfatia YS; Sharma A Indian J Dermatol Venereol Leprol; 2006; 72(5):383-4. PubMed ID: 17050939 [No Abstract] [Full Text] [Related]
11. In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders. Biswas P; Mantelli B; Hasson H; Vecchi A; Saniabadi A; Lazzarin A; Beretta A Clin Immunol; 2003 Dec; 109(3):355-8. PubMed ID: 14697751 [TBL] [Abstract][Full Text] [Related]
12. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to Namdev P; Patel S; Sparling B; Garg A Front Immunol; 2021; 12():647019. PubMed ID: 33995365 [TBL] [Abstract][Full Text] [Related]
13. [Apoptosis in HIV infection]. Maroto Vela Mdel C An R Acad Nac Med (Madr); 1994; 111(2):289-311; discussion 311-6. PubMed ID: 7810838 [No Abstract] [Full Text] [Related]
14. Lessons from people with nonprogressive HIV infection. Baltimore D N Engl J Med; 1995 Jan; 332(4):259-60. PubMed ID: 7808493 [No Abstract] [Full Text] [Related]